From: Preparation and evaluation of goose reovirus inactivated vaccine
Challenge time (dpv) | Group | Virus isolation from the swabs collected on different days after challenge: positive/total | Survival rate | Protection rate | OD value | |||||
---|---|---|---|---|---|---|---|---|---|---|
Day 3 | Day 7 | Day 12 | ||||||||
Oropharyngeal | Cloacal | Oropharyngeal | Cloacal | Oropharyngeal | Cloacal | |||||
7 | 0.2 mL | 1/5 | 1/5 | 0/4a | 0/4a | 0/4a | 1/4a | 80% | 60% | OD 0.45 |
0.5 mL | 0/5 | 0/5 | 0/5 | 0/5 | 0/5 | 1/5 | 100% | 80% | OD 0.47 | |
Control | 0/5 | 5/5 | 0/3a | 3/3a | 0/1a | 1/1a | 20% | 0% | OD 0.34 | |
12 | 0.2 mL | 0/5 | 1/5 | 0/4a | 0/4a | 0/4a | 0/4a | 80% | 80% | OD 0.57 |
0.5 mL | 0/5 | 0/5 | 0/5 | 0/5 | 0/5 | 0/5 | 100% | 100% | OD 0.60 | |
Control | 0/5 | 5/5 | 0/2a | 1/2 a | 0/2a | 1/2 a | 40% | 20% | OD 0.29 | |
27 | 0.2 mL | 0/5 | 0/5 | 0/5 | 0/5 | 0/5 | 0/5 | 100% | 100% | OD 0.82 |
0.5 mL | 0/5 | 0/5 | 0/5 | 0/5 | 0/5 | 0/5 | 100% | 100% | OD 0.96 | |
Control | 0/5 | 4/5 | 0/3a | 0/3 a | 0/3a | 0/3 a | 60% | 60% | OD 0.30 |